Sharon Hemond Hrynkow, Chief Scientific Officer at Cyclo Therapeutics, Inc. (CYTH), bought 1,000 shares at $4.98 ($5K) on 2021-12-02, disclosed to the SEC on 2021-12-02.
Open-market purchase of $5k CYTH by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CTDH | BUY | 2019-08-02 | $2K | — | Filing → |
| CTDH | BUY | 2019-07-31 | $2K | — | Filing → |